---
figid: PMC12109299__biomedicines-13-01153-g001
figtitle: HER2 signaling
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12109299
filename: biomedicines-13-01153-g001.jpg
figlink: /pmc/articles/PMC12109299/figure/F1/
number: F1
caption: 'Mechanism of HER2 signaling. This figure represents the signaling pathway
  leading to cancer cell survival and proliferation. Breast cancer is one of three
  cancers with the highest incidence of PIK3CA mutations. PTEN negatively regulates
  the PI3K cascade, inhibiting cell proliferation. HER2 receptors also interact with
  PUMA, resulting in its degradation and survival of the cancer cell. Abbreviations:
  RTK—receptor tyrosine kinase; PI3K—phosphoinositide 3-kinase; p85/p110—subunits
  of PI3K; PIP3—phosphatidylinositol (3,4,5)-trisphosphate; PIP2—phosphatidylinositol
  4,5-bisphosphate; Akt—protein kinase B; mTORC2—mTOR complex 2; PDK1—3-phosphoinositide
  dependent protein kinase-1; PUMA—p53-upregulated modulator of apoptosis; TSC2—tuberous
  sclerosis complex 2; TSC1—tuberous sclerosis complex 1; ERBB2—human epidermal growth
  factor receptor 2; PIK3CA—phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic
  subunit alpha; PTEN—phosphatase and tensin homolog deleted on chromosome ten'
papertitle: HER2-Positive Breast Cancer—Current Treatment Management and New Therapeutic
  Methods for Brain Metastasis
reftext: Hanna Miski, et al. Biomedicines. 2025 May;13(5).
year: '2025'
doi: 10.3390/biomedicines13051153
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: HER2-positive breast cancer | brain metastasis | trastuzumab | CNS | trastuzumab
  emtansine | metastatic breast cancer
automl_pathway: 0.9361535
figid_alias: PMC12109299__F1
figtype: Figure
redirect_from: /figures/PMC12109299__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12109299__biomedicines-13-01153-g001.html
  '@type': Dataset
  description: 'Mechanism of HER2 signaling. This figure represents the signaling
    pathway leading to cancer cell survival and proliferation. Breast cancer is one
    of three cancers with the highest incidence of PIK3CA mutations. PTEN negatively
    regulates the PI3K cascade, inhibiting cell proliferation. HER2 receptors also
    interact with PUMA, resulting in its degradation and survival of the cancer cell.
    Abbreviations: RTK—receptor tyrosine kinase; PI3K—phosphoinositide 3-kinase; p85/p110—subunits
    of PI3K; PIP3—phosphatidylinositol (3,4,5)-trisphosphate; PIP2—phosphatidylinositol
    4,5-bisphosphate; Akt—protein kinase B; mTORC2—mTOR complex 2; PDK1—3-phosphoinositide
    dependent protein kinase-1; PUMA—p53-upregulated modulator of apoptosis; TSC2—tuberous
    sclerosis complex 2; TSC1—tuberous sclerosis complex 1; ERBB2—human epidermal
    growth factor receptor 2; PIK3CA—phosphatidylinositol-4,5-bisphosphate 3-kinase
    catalytic subunit alpha; PTEN—phosphatase and tensin homolog deleted on chromosome
    ten'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BBC3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - EGFR
  - ERBB2
  - CUX1
  - SART3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PRKCA
  - PRRT2
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - PDK1
  - PDPK1
  - RPTOR
  - Insulin
---
